Ra Capital Management, L.p.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 85
Total Value: 5952606666
Accession Number: 0001104659-25-049549
Form Type: 13F-HR
CIK: 0001346824
Manager Name: Ra Capital Management, L.p.

Data Enrichment

91% identified

77 identified8 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

85 positions • $5,952,606.666K total value

85 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 2 of 5

Sort by:

GH Research PLC

GHRS|G3855L106

6944648(+3.9%)

Value:

$76.6B(+63.6%)

Apogee Therapeutics, Inc.

APGE|03770N101

1569491(+0.0%)

Value:

$58.6B(-17.5%)

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

2866733(+53.6%)

Value:

$52.0B(+27.8%)

Zai Lab Ltd

ZLAB|98887Q104

1295040(+0.0%)

Value:

$46.8B(+38.0%)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

5755577(+0.0%)

Value:

$45.6B(-37.4%)

Septerna, Inc.

SEPN|81734D104

6995858(+0.0%)

Value:

$40.5B(-74.7%)

Tourmaline Bio, Inc.

TRML|89157D105

2538925(+0.0%)

Value:

$38.6B(-25.0%)

Scholar Rock Holding Corp

SRRK|80706P103

1136453(+6351.3%)

Value:

$36.5B(+4698.9%)

UroGen Pharma Ltd.

URGN|M96088105

3206271

Value:

$35.5B

Artiva Biotherapeutics, Inc.

ARTV|04317A107

9853302(+0.0%)

Value:

$29.6B(-70.2%)

Fulcrum Therapeutics, Inc.

FULC|359616109

10229099(+0.0%)

Value:

$29.5B(-38.7%)

Vor Biopharma Inc.

VOR|929033108

39646039(+0.0%)

Value:

$28.4B(-35.4%)

Astria Therapeutics, Inc.

ATXS|04635X102

5105213(+0.0%)

Value:

$27.3B(-40.3%)

Kura Oncology, Inc.

KURA|50127T109

4004610(-10.0%)

Value:

$26.4B(-31.8%)

Structure Therapeutics Inc.

GPCR|86366E106

1517418(+0.0%)

Value:

$26.3B(-36.2%)

Cidara Therapeutics, Inc.

CDTX|171757206

1092796(+0.0%)

Value:

$23.5B(-19.9%)

008064107

9192092(+0.0%)

Value:

$23.1B(-5.3%)

IDEAYA Biosciences, Inc.

IDYA|45166A102

1347252(+0.0%)

Value:

$22.1B(-36.3%)

iTeos Therapeutics, Inc.

ITOS|46565G104

3649057(+74.4%)

Value:

$21.8B(+35.6%)

Travere Therapeutics, Inc.

TVTX|89422G107

1150000(+0.0%)

Value:

$20.6B(+2.9%)

Instrument	Shares		Other Manager	Value
Gh Research Plc(GHRScusipG3855L106)	6.9M	QoQ +3.85% (+258.0K) YoY NEW(+6.9M)	All Managers (Combined)	$76.6M	QoQ +63.65% (+$29.8M) YoY NEW(+$76.6M)
Apogee Therapeutics, Inc.(APGEcusip03770N101)	1.6M	QoQ 0.00% (-0) YoY NEW(+1.6M)	All Managers (Combined)	$58.6M	QoQ -17.52% (-$12.5M) YoY NEW(+$58.6M)
Dianthus Therapeutics, Inc. /De/(DNTHcusip252828108)	2.9M	QoQ +53.59% (+1.0M) YoY NEW(+2.9M)	All Managers (Combined)	$52.0M	QoQ +27.80% (+$11.3M) YoY NEW(+$52.0M)
Zai Lab Ltd(ZLABcusip98887Q104)	1.3M	QoQ 0.00% (+0) YoY NEW(+1.3M)	All Managers (Combined)	$46.8M	QoQ +37.99% (+$12.9M) YoY NEW(+$46.8M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	5.8M	QoQ 0.00% (-0) YoY NEW(+5.8M)	All Managers (Combined)	$45.6M	QoQ -37.41% (-$27.3M) YoY NEW(+$45.6M)
Septerna, Inc.(SEPNcusip81734D104)	7.0M	QoQ 0.00% (-0) YoY NEW(+7.0M)	All Managers (Combined)	$40.5M	QoQ -74.71% (-$119.7M) YoY NEW(+$40.5M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	2.5M	QoQ 0.00% (-0) YoY NEW(+2.5M)	All Managers (Combined)	$38.6M	QoQ -25.00% (-$12.9M) YoY NEW(+$38.6M)
Scholar Rock Holding Corp(SRRKcusip80706P103)	1.1M	QoQ +6351.25% (+1.1M) YoY NEW(+1.1M)	All Managers (Combined)	$36.5M	QoQ +4698.88% (+$35.8M) YoY NEW(+$36.5M)
Urogen Pharma Ltd.(URGNcusipM96088105)	3.2M	QoQ NEW(+3.2M) YoY NEW(+3.2M)	All Managers (Combined)	$35.5M	QoQ NEW(+$35.5M) YoY NEW(+$35.5M)
Artiva Biotherapeutics, Inc.(ARTVcusip04317A107)	9.9M	QoQ 0.00% (-0) YoY NEW(+9.9M)	All Managers (Combined)	$29.6M	QoQ -70.23% (-$69.8M) YoY NEW(+$29.6M)
Fulcrum Therapeutics, Inc.(FULCcusip359616109)	10.2M	QoQ 0.00% (-0) YoY NEW(+10.2M)	All Managers (Combined)	$29.5M	QoQ -38.72% (-$18.6M) YoY NEW(+$29.5M)
Vor Biopharma Inc.(VORcusip929033108)	39.6M	QoQ 0.00% (-0) YoY NEW(+39.6M)	All Managers (Combined)	$28.4M	QoQ -35.36% (-$15.6M) YoY NEW(+$28.4M)
Astria Therapeutics, Inc.(ATXScusip04635X102)	5.1M	QoQ 0.00% (-0) YoY NEW(+5.1M)	All Managers (Combined)	$27.3M	QoQ -40.26% (-$18.4M) YoY NEW(+$27.3M)
Kura Oncology, Inc.(KURAcusip50127T109)	4.0M	QoQ -10.02% (-446.4K) YoY NEW(+4.0M)	All Managers (Combined)	$26.4M	QoQ -31.82% (-$12.3M) YoY NEW(+$26.4M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	1.5M	QoQ 0.00% (-0) YoY NEW(+1.5M)	All Managers (Combined)	$26.3M	QoQ -36.17% (-$14.9M) YoY NEW(+$26.3M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	1.1M	QoQ 0.00% (-0) YoY NEW(+1.1M)	All Managers (Combined)	$23.5M	QoQ -19.86% (-$5.8M) YoY NEW(+$23.5M)
(cusip008064107)✕	9.2M	QoQ 0.00% (-0) YoY NEW(+9.2M)	All Managers (Combined)	$23.1M	QoQ -5.28% (-$1.3M) YoY NEW(+$23.1M)
Ideaya Biosciences, Inc.(IDYAcusip45166A102)	1.3M	QoQ 0.00% (-0) YoY NEW(+1.3M)	All Managers (Combined)	$22.1M	QoQ -36.26% (-$12.6M) YoY NEW(+$22.1M)
Iteos Therapeutics, Inc.(ITOScusip46565G104)	3.6M	QoQ +74.40% (+1.6M) YoY NEW(+3.6M)	All Managers (Combined)	$21.8M	QoQ +35.57% (+$5.7M) YoY NEW(+$21.8M)
Travere Therapeutics, Inc.(TVTXcusip89422G107)	1.1M	QoQ 0.00% (+0) YoY NEW(+1.1M)	All Managers (Combined)	$20.6M	QoQ +2.87% (+$575.0K) YoY NEW(+$20.6M)